Loading clinical trials...
Loading clinical trials...
Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury - A Randomized Control Trial
The standard of care for treatment of burn injury is to inject a solution of epinephrine under the skin of the injured site in order to reduce blood loss during skin grafting. This solution of epinephrine has been shown to have effects on the body outside the donor site. Some people have increases in heart rate and blood pressure. We will study the effect of a phenylephrine solution in place of an epinephrine solution to control blood loss. We think that phenylephrine will help decrease blood loss and not change blood pressure or heart rate. The injured area will be injected under the skin and a skin graft will be taken in the same way as we usually do. The only change will be the use of phenylephrine in the solution instead of epinephrine. Our goal is to find whether or not phenylephrine or epinephrine solution results in a reduction of blood loss without affecting the rest of the body.
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
No
University of Manitoba
Winnipeg, Manitoba, Canada
Start Date
December 1, 2014
Primary Completion Date
June 1, 2026
Completion Date
December 1, 2027
Last Updated
December 5, 2024
24
ESTIMATED participants
Phenylephrine
DRUG
Lead Sponsor
University of Manitoba
NCT06601582
NCT06428682
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06638749